Catalyst Wire Dossier Catalyst Wire Dossier

Vuity

pilocarpine
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Vuity, covering 2021-10-28 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia [EARLY_Phase 1]

See pricing